Exo, Inc.
United StatesFDA 510(k) applicant, unverified
- Devices
- 5
What Exo, Inc. makes
Exo, Inc. develops AI-driven diagnostic platforms and medical devices, including the HEMOCLAV venous catheter for vascular access. Their portfolio also includes AI-based monitoring solutions for bladder, lung, and strain measurements, designed to assist in clinical assessments.
These devices are classified as Class II under FDA regulations and are listed in the 510(k) clearance registry. The company is based in the United States.
Catalogue
AI Platform (AIP001) Ref K232501
510(k) 510(k)Hemoclav Venous Catheter Ref K831801
510(k) 510(k)Bladder AI (AIBV01) Ref K230497
510(k) 510(k)Lung AI (LAI001) Ref K243239
510(k) 510(k)Strain AI (SAI001) Ref K242359
510(k) 510(k)
Frequently asked questions
How many devices does Exo, Inc. have in the registry?
The registry currently lists 5 devices for Exo, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Exo, Inc.'s devices?
Among its 5 most recently registered devices, Exo, Inc. has devices listed in FDA 510(k) (5 devices).
What risk classes do Exo, Inc.'s devices fall under?
Among its 5 most recently registered devices, the classes recorded for Exo, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Exo, Inc. in the registry?
The most recently registered devices listed for Exo, Inc. include AI Platform (AIP001), HEMOCLAV VENOUS CATHETER, Bladder AI (AIBV01) and Lung AI (LAI001).